FindTrial
Sign In

Single-cell sequencing study of lymphoma

Single-cell sequencing study of lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050183
Enrollment
Unknown
Registered
2021-08-21
Start date
2021-08-17
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphoma

Interventions

experimental group:Nil
control group:Nil

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients >= 18 years of age; 2. Clinically highly suspected lymphoma; 3. Lymph node biopsy and pathological diagnosis are required; 4. Informed consent can be signed independently.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Single-cell sequencing study;—

Countries

China

Contacts

Public ContactXu Caigang

West China Hospital, Sichuan University

1024301862@qq.com+86 18980601083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026